| Bioactivity | PPACK TFA is a plasminogen activator (rt-PA) inhibitor. PPACK TFA can inhibit changes in fibrin degradation products, plasminogen and alpha 2-antiplasmin. PPACK TFA also inhibits the binding of rt-PA to plasma protease inhibitors[1]. |
| Name | PPACK TFA |
| CAS | 157379-44-7 |
| Formula | C23H32ClF3N6O5 |
| Molar Mass | 564.99 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Mohler MA, et al. D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Thromb Haemost. 1986;56(2):160-164. |
PPACK TFA
CAS: 157379-44-7 F: C23H32ClF3N6O5 W: 564.99
PPACK TFA is a plasminogen activator (rt-PA) inhibitor. PPACK TFA can inhibit changes in fibrin degradation products, pl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.